Market Definition and Introduction
The global membrane chromatography market is witnessing unprecedented growth and is set to grow from an estimated USD 832.4 million in 2024 to USD 1,660.04 million by 2035, at a high CAGR of 16.0% for the analysis period (2025–2035). As pharmaceutical manufacturing shifts towards high-throughput and continuous purification processes, membrane chromatography has positioned itself as an indispensable technology for bioseparation. For biomanufacturers to minimise process complexity, increase scalability, and satisfy regulatory needs, the ramping up of the integration of membrane-based systems for downstream processing into a strategic imperative across the biologics value chain has become paramount.
Membrane chromatography is distinguished by its promise of fast processing, high binding capacities, and reduced buffer consumption. The advantages forced CDMOs and in-house biopharma facilities to make the switch away from traditional resin-packed columns toward membrane-based systems, particularly in late-phase clinical and commercial production. The increasing demand for this technique is driven by its unique capacity to purify large biomolecules (e.g., viral vectors, monoclonal antibodies, and recombinant proteins) while allowing easy integration with single-use systems.
Regulatory agencies across the globe tighten purification and contamination control requirements, membrane chromatography becomes ever more preferred on the grounds of its capability for viral clearance, endotoxin removal, and impurity profiling. The market leaders invest huge amounts in R&D for optimising membrane formats, binding chemistries, and pore structures that can fit the emerging therapeutic modalities. In turn, development in this regard, coupled with increasingly pressing demands on manufacturers for rapid time-to-market, represents a considerable growth opportunity for global investment in membrane chromatography systems.
Recent Developments in the Industry
In February 2024, Sartorius AG announced the expansion of its chromatography portfolio by launching a new range of high-capacity membrane capsules aimed at improving process scalability and performance in viral vector purification.
In October 2023, Thermo Fisher Scientific introduced its latest generation of membrane filter cartridges designed to enhance viral clearance and protein purification in large-scale vaccine manufacturing workflows.
In May 2023, Danaher Corporation disclosed a strategic internal realignment that will unify its Cytiva and Pall Life Sciences units under a single bioprocessing platform, streamlining its chromatography innovations and operational synergies.
Market Dynamics
Increased Biopharmaceutical Production Increases Demand for High-Throughput Purification Technology
Growing demand worldwide for biologics, biosimilars, and advanced therapies is thus promoting the use of membrane chromatography. As biopharmaceutical companies continually seek shorter timelines and better economics in their production, membrane-based purification becomes an attractive candidate for realising these objectives. Fast processing, scalability, and flexibility in operation make the technology well placed to meet the urgent needs for cost-effective downstream solutions. Furthermore, the increased R&D into vaccines and cell therapies has driven innovations in hybrid membrane technologies that incorporate high-capacity ligands onto disposable systems for single-use processing.
Regulatory Focus on GMP-Grade and Single-Use Systems Boosting Market Growth
Global stringent regulatory frameworks, such as those of the FDA and EMA, insist on higher product purity and traceability in biopharmaceutical manufacture, which resulted in the adoption of validated, GMP-grade membrane chromatography systems by manufacturers because they largely cut down risks for contamination, as well as providing reproducible purification. The trend for single-use and pre-validated membrane devices is growing rapidly as manufacturers move seamlessly to meet cGMP regulations with specific flexibility in manufacturing.
High Initial Investment Cost and Limited Diversity of Ligand Offers Temporary Constraints
Thus far, the only noticeable cost factor in the membrane chromatography market is cost. Construction of high-performance membrane systems, especially in terms of large-scale biologics, entails huge upfront capital expenditure. Moreover, a very limited number of affinity ligands match membrane systems, which also limits the application range of membrane chromatography, especially for niche biologic purification. However, it is foretold that these challenges will be improved over time with increased research and development investments and innovations in modular systems.
Technological Innovations in Hybrid Continuous Purification Open New Frontiers for Growth
The shift toward continuous bioprocessing and hybrid purification trains has unlocked further growth avenues for the industry. Such approaches integrate ion-exchange and affinity membrane chromatography with continuous manufacturing platforms, enabling real-time product recoveries and reduced process variability. Additionally, organisations investing in modular automated purification solutions enhance competitiveness with rapid scale-up and greater process consistency, both of which are critical in meeting the growing demand for biologics and vaccines.
New Currents in Disposable Bioprocessing and Sustainability Revolutionise Downstream Operations
Sustainability strategy in the biopharma industry is driving increased uptake of green, disposable membrane chromatography systems. Environments are increasingly being developed by manufacturers where membrane modules can be recycled, and chemistries leading to solvent-free purifications will also increase in number. Also, digitally monitored purification—that is, with real-time analytics and AI-driven process control—will revolutionise how manufacturers optimise yield and batch integrity to give room for the next step in the operational excellence of the industry.
Attractive Opportunities in the Market
• Growing Biopharmaceutical Pipeline – Rising approvals of complex biologics demand advanced downstream processing methods
• Surge in Cell and Gene Therapy – Viral vector purification pushes rapid uptake of membrane solutions
• Emergence of Single-Use Bioprocessing – Disposable membrane systems fit next-gen flexible manufacturing models
• High Throughput Processing – Rapid purification protocols reduce bottlenecks and increase output
• Automation & Smart Skid Integration – AI and real-time control boost process reliability and reproducibility
• Regulatory Reinforcement – Compliance-driven purification solutions strengthen end-product safety and approval timelines
• Continuous Bioprocessing Trend – Membrane units streamline transition to uninterrupted purification workflows
• Innovation in Membrane Chemistry – Functionalized membranes deliver enhanced selectivity and loading capacities
Report Segmentation
By Product: Capsules, Cassette & Cartridges, Syringe Filters, Membrane Filters, Filter Plates, Spin Columns, Others
By Technique: Ion Exchange Membrane Chromatography, Affinity Membrane Chromatography, Hydrophobic Interaction Membrane Chromatography (HIMC)
By End Use: Pharmaceutical and Biotechnology Companies, CRO and CMO, Academic Research Institutes
By Region: North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Spain, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, Rest of Asia-Pacific), LAMEA (Brazil, Argentina, UAE, Saudi Arabia (KSA), Africa Rest of Latin America)
Key Market Players: Sartorius AG, Merck KGaA, Danaher Corporation (Cytiva and Pall), Thermo Fisher Scientific Inc., 3M Company, Asahi Kasei Corporation, Parker Hannifin Corporation, GVS Group, Repligen Corporation, and Membrane Solutions LLC.
Report Aspects
• Base Year: 2024
• Historic Years: 2022, 2023, 2024
• Forecast Period: 2025-2035
• Report Pages: 293
Dominating Segments
Ion Exchange Membrane Chromatography Dominates Owing to Its Broad Applicability and High Purity Recovery Rates
Ion exchange membrane chromatography is still holding a leading position in the global arena because of its immense capabilities for the removal of charged impurities from biological feeds and for accomplishing superior purification of proteins. Increased complexities in the manufacturing of biologics-monoclonal antibodies, and recombinant proteins-have rendered it indispensable for the technology to deliver high amounts of purity on shorter residence time. The versatility of this method for implementing both anion exchange and cation exchange modifications renders seamless adoption of its modular technologies into downstream workflows. Its additional merit of being scalable and affordable side more relevance toward manufacturers aiming for flexible-sized batches and expeditious production cycles with respect to cGMP guidance.
Affinity Membrane Chromatography Gains Momentum Driven by Precision Biologic Purification Needs
Affinity membrane chromatography is fast emerging as a paradigm-different technology for the purification of complex biomolecules such as viral vectors, antibodies, and recombinant proteins. The technology exploits highly specific ligand interactions so as to give unmatched selectivity and yield. The burgeoning field of manufacturing gene and cell therapies has hastened the uptake of this technology, which offers faster processing and higher purity via affinity membranes compared to conventional column methods. Investments into ligand engineering are fostering the development of membranes, allowing application across various biologic classes. Increasing availability of protein A and custom ligand membranes is setting new records in process efficiency and throughput.
Pharmaceutical and Biotechnology Companies Segment Leads with Expanding Biologic Production Capacities
The largest end-use segment includes pharmaceutical and biotechnology companies, which are being promoted by the increasing global demand for biologics, biosimilars, and advanced therapies. These organisations are in active transformation of their downstream operations to incorporate single-use membrane chromatography systems, which provide scalability, compliance, and time efficiency. The accelerating spread of contract manufacturing, coupled with an influx of start-up biotech firms developing niche therapeutics, has further aided in this adoption. With the ongoing scale-up of GMP-certified biomanufacturing facilities in the U.S., Europe, and Asia, this segment will become dominant through the predicted period.
Key Takeaways in the Membrane Chromatography Market
• High-performance membranes revolutionise downstream processing across therapeutic pipelines
• Single-use capsule and cartridge solutions dominate high-throughput biomanufacturing
• Viral vector and gene therapy boom catalyses demand for precise purification technologies
• Modular and disposable facilities drive uptake of membrane-based solutions
• Membrane filters provide robust impurity clearance for regulatory readiness
• Smart purification platforms integrate real-time analytics to boost yield and accuracy
• Asia-Pacific biomanufacturing surge fuels rapid membrane system deployment
• Cross-functional product formats ensure scalability from lab to commercial scale
• Chromatography automation reduces operator dependency and process variability
• Strategic collaborations across CDMOs and biotech firms amplify membrane adoption
Regional Insights
North America's dominating foothold in the global membrane chromatography market
An advanced biopharmaceutical ecosystem, strong regulatory frameworks, and deep-rooted R&D infrastructure have solidified North America's dominating foothold in the global membrane chromatography market. The United States stands out as the centre of innovation, where key players invest considerable resources into single-use technologies for purification and into continuous bioprocessing systems. The area's increase in gene therapy development, in combination with rising investment into US domestic biologic manufacturing capacity, is accelerating the integration of membrane technologies. Additionally, the developing supportive FDA infrastructure concerning fast-track drug approvals has encouraged biotech companies to escalate the adoption of scalable purification systems that incorporate compliance and operational flexibility.
Europe Tops the Charts in Developing Innovations on Green and Regulatory-Compliant Chromatography Capacity
Europe is now, thanks to the imposition of very strong social and environmental directives by the EU, no doubt the world leader in terms of green membrane chromatography. It is Germany, the UK, and France leading this regional effort from targeted investments into green biomanufacturing and solvent-free purification technologies. In Europe, biopharmaceutical companies are converting from resin-based columns to membrane systems developed and compliant vis-a-vis REACH and GMP sustainability requirements. Also, in this regard, cooperation among research institutions and technology providers within Europe will develop circular membrane recycling and ligand regeneration concepts in accordance with the continent's Green Deal objectives.
Asia-Pacific Witnessed the Fastest Growth on the Back of Emerging Biotech Clusters and Precisely Government-Backed Initiatives
Asia-Pacific appears to be the fastest in terms of projections for CAGR in the years to come, with a quickly growing base of pharmaceutical manufacturing units, particularly in China, India, and South Korea. Massive local investments into bioprocessing infrastructures, coupled with the generous governmental incentives given for taking up biologic production, are furthering penetration into membrane chromatography. The emergence of local CMOs and biosimilar developers is creating a stronger demand for high-level, scalable purification methods, which, in turn, brings about further need for their applications. As more APAC nations put in place regulatory frameworks that align with the world's GMP standards, they are seen to be turning into the future global centre for the inexpensive yet still high-quality production of biopharmaceuticals.
Steady Uptake in Bioprocessing Modernisation and Import Substitution Strategies in LAMEA Markets
In fact, Latin America, the Middle East, and Africa collectively constitute the LAMEA region, and all of these have been steadily adopting newer forms of membrane chromatography as part of more comprehensive reforms towards industrial modernisation. Investments in local capabilities for manufacturing vaccines along with biosimilars are more prevalent in those countries, such as Brazil and Saudi Arabia, bolstering self-reliance in health supply chains. The removal of formal barriers that currently inhibit progressive government initiatives to push biopharma innovation and collaborations with global technology providers to contribute to the gradual transition from traditional purification methods to modern membrane systems is being experienced in many countries of the LAMEA markets. While this is very much in its early stages of adoption, it is a real long-term prospect for these markets in the LAMEA, particularly concerning strategic efforts to localise capabilities in high-value bioprocessing.
Core Strategic Questions Answered in This Report
Q. What is the expected growth trajectory of the membrane chromatography market from 2024 to 2035?
The global membrane chromatography market is anticipated to grow from USD 832.4 million in 2024 to USD 1,660.04 million by 2035, exhibiting a robust CAGR of 16.0%. This accelerated growth is attributed to the rising demand for scalable, single-use, and high-throughput purification technologies across biopharmaceutical manufacturing, particularly in gene therapy and mRNA vaccine production.
Q. Which key factors are fuelling the growth of the membrane chromatography market?
Several pivotal factors are propelling the membrane chromatography market:
• Rapid growth of biologics, biosimilars, and cell and gene therapies
• Shift toward single-use, continuous bioprocessing systems
• Increasing regulatory scrutiny for viral clearance and impurity removal
• Technological innovations in membrane design and functionalization
• Rising outsourcing trends across CDMOs and CROs for purification needs
• Growing demand for cost-effective, scalable, and flexible downstream solutions
Q. What are the primary challenges hindering the growth of the membrane chromatography market?
Key challenges include:
• High upfront costs of advanced membrane systems for small players
• Limited reusability of membranes in some formats
• Technical expertise required to optimise membrane use across platforms
• Regional disparities in infrastructure for chromatography validation
• Challenges in transitioning from resin-based columns in legacy setups
Q. Which regions currently lead the membrane chromatography market in terms of market share?
North America holds the dominant position in the membrane chromatography market, driven by its mature biopharmaceutical ecosystem and regulatory rigour. Europe follows closely with its advanced research infrastructure and strong compliance frameworks. Asia-Pacific is quickly emerging as a high-growth region due to government-backed biologics production initiatives.
Q. What emerging opportunities are anticipated in the membrane chromatography market?
Emerging opportunities include:
• Expansion of continuous bioprocessing frameworks integrating membrane platforms
• Innovation in membrane coatings and binding chemistries for enhanced purification
• Smart skid systems enabling automation and real-time analytics
• Development of membrane formats tailored to gene therapy and mRNA purification
• Rapid adoption in emerging markets with growing biologics infrastructure
Key Benefits for Stakeholders
• The report offers a quantitative assessment of market segments, emerging trends, projections, and market dynamics for the period 2024 to 2035.
• The report presents comprehensive market research, including insights into key growth drivers, challenges, and potential opportunities.
• Porter's Five Forces analysis evaluates the influence of buyers and suppliers, helping stakeholders make strategic, profit-driven decisions and strengthen their supplier-buyer relationships.
• A detailed examination of market segmentation helps identify existing and emerging opportunities.
• Key countries within each region are analysed based on their revenue contributions to the overall market.
• The positioning of market players enables effective benchmarking and provides clarity on their current standing within the industry.
• The report covers regional and global market trends, major players, key segments, application areas, and strategies for market expansion.

Chapter 1. Market Snapshot

1.1. Market Definition & Report Overview
1.2. Market Segmentation
1.3. Key Takeaways
1.3.1. Top Investment Pockets
1.3.2. Top Winning Strategies
1.3.3. Market Indicators Analysis
1.3.4. Top Impacting Factors
1.4. Industry Ecosystem Analysis
1.4.1. 360’ Analysis

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4 Market Attractiveness Analysis (top leader’s point of view on market)
2.5.key Findings

Chapter 3. Research Methodology

3.1 Research Objective
3.2 Supply Side Analysis
3.1.1. Primary Research
3.1.2. Secondary Research
3.3 Demand Side Analysis
3.1.3. Primary Research
3.1.4. Secondary Research
3.2. Forecasting Models
3.2.1. Assumptions
3.2.2. Forecasts Parameters
3.3. Competitive breakdown
3.3.1. Market Positioning
3.3.2. Competitive Strength
3.4. Scope of the Study
3.4.1. Research Assumption
3.4.2. Inclusion & Exclusion
3.4.3. Limitations

Chapter 4. Industry Landscape

4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Porter’s 5 Forces Model
4.2.1. Bargaining Power of Buyer
4.2.2. Bargaining Power of Supplier
4.2.3. Threat of New Entrants
4.2.4. Threat of Substitutes
4.2.5. Competitive Rivalry
4.3. Value Chain Analysis
4.4. PESTEL Analysis
4.5. Pricing Analysis and Trends
4.6. Key growth factors and trends analysis
4.7. Market Share Analysis (2025)
4.8. Top Winning Strategies (2025)
4.9. Trade Data Analysis (Import Export)
4.10. Regulatory Guidelines
4.11. Historical Data Analysis
4.12. Analyst Recommendation & Conclusion

Chapter 5. Global Membrane Chromatography Market Size & Forecasts by Product 2025-2035

5.1. Market Overview
5.1.1. Market Size and Forecast By Product 2025-2035
5.2. Capsules
5.2.1. Market definition, current market trends, growth factors, and opportunities
5.2.2. Market size analysis, by region, 2025-2035
5.2.3. Market share analysis, by country, 2025-2035
5.3. Cassettes & Cartridges
5.3.1. Market definition, current market trends, growth factors, and opportunities
5.3.2. Market size analysis, by region, 2025-2035
5.3.3. Market share analysis, by country, 2025-2035
5.4. Syringe Filters
5.4.1. Market definition, current market trends, growth factors, and opportunities
5.4.2. Market size analysis, by region, 2025-2035
5.4.3. Market share analysis, by country, 2025-2035
5.5. Membrane Filters
5.5.1. Market definition, current market trends, growth factors, and opportunities
5.5.2. Market size analysis, by region, 2025-2035
5.5.3. Market share analysis, by country, 2025-2035
5.6. Filter Plates
5.6.1. Market definition, current market trends, growth factors, and opportunities
5.6.2. Market size analysis, by region, 2025-2035
5.6.3. Market share analysis, by country, 2025-2035
5.7. Spin Columns
5.7.1. Market definition, current market trends, growth factors, and opportunities
5.7.2. Market size analysis, by region, 2025-2035
5.7.3. Market share analysis, by country, 2025-2035
5.8. Others
5.8.1. Market definition, current market trends, growth factors, and opportunities
5.8.2. Market size analysis, by region, 2025-2035
5.8.3. Market share analysis, by country, 2025-2035

Chapter 6. Global Membrane Chromatography Market Size & Forecasts by Technique 2025-2035

6.1. Market Overview
6.1.1. Market Size and Forecast By Technique 2025-2035
6.2. Ion Exchange Membrane Chromatography
6.2.1. Market definition, current market trends, growth factors, and opportunities
6.2.2. Market size analysis, by region, 2025-2035
6.2.3. Market share analysis, by country, 2025-2035
6.3. Affinity Membrane Chromatography
6.3.1. Market definition, current market trends, growth factors, and opportunities
6.3.2. Market size analysis, by region, 2025-2035
6.3.3. Market share analysis, by country, 2025-2035
6.4. Hydrophobic Interaction Membrane Chromatography (HIMC)
6.4.1. Market definition, current market trends, growth factors, and opportunities
6.4.2. Market size analysis, by region, 2025-2035
6.4.3. Market share analysis, by country, 2025-2035

Chapter 7. Global Membrane Chromatography Market Size & Forecasts by End Use 2025-2035

7.1. Market Overview
7.1.1. Market Size and Forecast By End Use 2025-2035
7.2. Pharmaceutical and Biotechnology Companies
7.2.1. Market definition, current market trends, growth factors, and opportunities
7.2.2. Market size analysis, by region, 2025-2035
7.2.3. Market share analysis, by country, 2025-2035
7.3. CRO and CMO
7.3.1. Market definition, current market trends, growth factors, and opportunities
7.3.2. Market size analysis, by region, 2025-2035
7.3.3. Market share analysis, by country, 2025-2035
7.4. Academic Research Institutes
7.4.1. Market definition, current market trends, growth factors, and opportunities
7.4.2. Market size analysis, by region, 2025-2035
7.4.3. Market share analysis, by country, 2025-2035

Chapter 8. Global Membrane Chromatography Market Size & Forecasts by Region 2025–2035

8.1. Regional Overview 2025-2035
8.2. Top Leading and Emerging Nations
8.3. North America Membrane Chromatography Market
8.3.1. U.S. Membrane Chromatography Market
8.3.1.1. Product breakdown size & forecasts, 2025-2035
8.3.1.2. Technique breakdown size & forecasts, 2025-2035
8.3.1.3. End Use breakdown size & forecasts, 2025-2035
8.3.2. Canada Membrane Chromatography Market
8.3.2.1. Product breakdown size & forecasts, 2025-2035
8.3.2.2. Technique breakdown size & forecasts, 2025-2035
8.3.2.3. End Use breakdown size & forecasts, 2025-2035
8.3.3. Mexico Membrane Chromatography Market
8.3.3.1. Product breakdown size & forecasts, 2025-2035
8.3.3.2. Technique breakdown size & forecasts, 2025-2035
8.3.3.3. End Use breakdown size & forecasts, 2025-2035
8.4. Europe Membrane Chromatography Market
8.4.1. UK Membrane Chromatography Market
8.4.1.1. Product breakdown size & forecasts, 2025-2035
8.4.1.2. Technique breakdown size & forecasts, 2025-2035
8.4.1.3. End Use breakdown size & forecasts, 2025-2035
8.4.2. Germany Membrane Chromatography Market
8.4.2.1. Product breakdown size & forecasts, 2025-2035
8.4.2.2. Technique breakdown size & forecasts, 2025-2035
8.4.2.3. End Use breakdown size & forecasts, 2025-2035
8.4.3. France Membrane Chromatography Market
8.4.3.1. Product breakdown size & forecasts, 2025-2035
8.4.3.2. Technique breakdown size & forecasts, 2025-2035
8.4.3.3. End Use breakdown size & forecasts, 2025-2035
8.4.4. Spain Membrane Chromatography Market
8.4.4.1. Product breakdown size & forecasts, 2025-2035
8.4.4.2. Technique breakdown size & forecasts, 2025-2035
8.4.4.3. End Use breakdown size & forecasts, 2025-2035
8.4.5. Italy Membrane Chromatography Market
8.4.5.1. Product breakdown size & forecasts, 2025-2035
8.4.5.2. Technique breakdown size & forecasts, 2025-2035
8.4.5.3. End Use breakdown size & forecasts, 2025-2035
8.4.6. Rest of Europe Membrane Chromatography Market
8.4.6.1. Product breakdown size & forecasts, 2025-2035
8.4.6.2. Technique breakdown size & forecasts, 2025-2035
8.4.6.3. End Use breakdown size & forecasts, 2025-2035
8.5. Asia Pacific Membrane Chromatography Market
8.5.1. China Membrane Chromatography Market
8.5.1.1. Product breakdown size & forecasts, 2025-2035
8.5.1.2. Technique breakdown size & forecasts, 2025-2035
8.5.1.3. End Use breakdown size & forecasts, 2025-2035
8.5.2. India Membrane Chromatography Market
8.5.2.1. Product breakdown size & forecasts, 2025-2035
8.5.2.2. Technique breakdown size & forecasts, 2025-2035
8.5.2.3. End Use breakdown size & forecasts, 2025-2035
8.5.3. Japan Membrane Chromatography Market
8.5.3.1. Product breakdown size & forecasts, 2025-2035
8.5.3.2. Technique breakdown size & forecasts, 2025-2035
8.5.3.3. End Use breakdown size & forecasts, 2025-2035
8.5.4. Australia Membrane Chromatography Market
8.5.4.1. Product breakdown size & forecasts, 2025-2035
8.5.4.2. Technique breakdown size & forecasts, 2025-2035
8.5.4.3. End Use breakdown size & forecasts, 2025-2035
8.5.5. South Korea Membrane Chromatography Market
8.5.5.1. Product breakdown size & forecasts, 2025-2035
8.5.5.2. Technique breakdown size & forecasts, 2025-2035
8.5.5.3. End Use breakdown size & forecasts, 2025-2035
8.5.6. Rest of APAC Membrane Chromatography Market
8.5.6.1. Product breakdown size & forecasts, 2025-2035
8.5.6.2. Technique breakdown size & forecasts, 2025-2035
8.5.6.3. End Use breakdown size & forecasts, 2025-2035
8.6. LAMEA Membrane Chromatography Market
8.6.1. Brazil Membrane Chromatography Market
8.6.1.1. Product breakdown size & forecasts, 2025-2035
8.6.1.2. Technique breakdown size & forecasts, 2025-2035
8.6.1.3. End Use breakdown size & forecasts, 2025-2035
8.6.2. Argentina Membrane Chromatography Market
8.6.2.1. Product breakdown size & forecasts, 2025-2035
8.6.2.2. Technique breakdown size & forecasts, 2025-2035
8.6.2.3. End Use breakdown size & forecasts, 2025-2035
8.6.3. UAE Membrane Chromatography Market
8.6.3.1. Product breakdown size & forecasts, 2025-2035
8.6.3.2. Technique breakdown size & forecasts, 2025-2035
8.6.3.3. End Use breakdown size & forecasts, 2025-2035
8.6.4. Saudi Arabia (KSA Membrane Chromatography Market
8.6.4.1. Product breakdown size & forecasts, 2025-2035
8.6.4.2. Technique breakdown size & forecasts, 2025-2035
8.6.4.3. End Use breakdown size & forecasts, 2025-2035
8.6.5. Africa Membrane Chromatography Market
8.6.5.1. Product breakdown size & forecasts, 2025-2035
8.6.5.2. Technique breakdown size & forecasts, 2025-2035
8.6.5.3. End Use breakdown size & forecasts, 2025-2035
8.6.6. Rest of LAMEA Membrane Chromatography Market
8.6.6.1. Product breakdown size & forecasts, 2025-2035
8.6.6.2. Technique breakdown size & forecasts, 2025-2035
8.6.6.3. End Use breakdown size & forecasts, 2025-2035

Chapter 9. Company Profiles

9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Sartorius AG
9.2.1.1. Company Overview
9.2.1.2. Key Executives
9.2.1.3. Company Snapshot
9.2.1.4. Financial Performance (Subject to Data Availability)
9.2.1.5. Product/Services Port
9.2.1.6. Recent Development
9.2.1.7. Market Strategies
9.2.1.8. SWOT Analysis
9.2.2. Merck KGaA
9.2.3. Danaher Corporation (Cytiva and Pall)
9.2.4. Thermo Fisher Scientific Inc.
9.2.5. 3M Company
9.2.6. Asahi Kasei Corporation
9.2.7. Parker Hannifin Corporation
9.2.8. GVS Group
9.2.9. Repligen Corporation
9.2.10. Membrane Solutions LLC